During the past decade, Comfort Inn conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Comfort Inn" are "Smoking" (5 trials), "Tobacco Use Disorder" (5 trials) and "Tobacco Dependence" (1 trials). Many other conditions were trialed in "Comfort Inn" in a lesser frequency.

Most popular intervention types in "Comfort Inn" are "Other" (4 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ariva Silver Wintergreen" (2 trials), "Anatabloc(TM)" (1 trials), "Ariva Wintergreen" (1 trials), "Ariva® Silver Wintergreen" (1 trials) and "CigRx Lozenge" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comfort Inn" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Comfort Inn". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Comfort Inn, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Comfort Inn, 5 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".